We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cellular Dynamics Partners with iPS Academia Japan to In-License Seminal iPS Cell Patent Portfolio

News   May 10, 2010

 
Cellular Dynamics Partners with iPS Academia Japan to In-License Seminal iPS Cell Patent Portfolio
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News

The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue hydroxychloroquine and lopinavir/ritonavir study arms.

READ MORE

Quick and Simple Technology Enhances the Potential of Stem Cells To Differentiate Into Adult Cells

News

Researchers have developed a new, simple and fast technology that enhances in vitro and in vivo the potential of stem cells to differentiate into adult cells.

READ MORE

Long-term Culture of Human Pancreatic Slices Reveals Regeneration of Beta Cells

News

Breakthrough technology to preserve live pancreatic tissue for at least ten days provides a window into the organ's ability to regenerate. The use of this system as a model to study pancreatic regeneration could have important therapeutic implications for the treatment of diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE